NCT07652606

Brief Summary

Provide single patient expanded access to RGX-202 for eligible patients

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 20, 2026

Completed
28 days until next milestone

First Posted

Study publicly available on registry

June 17, 2026

Completed
Last Updated

June 17, 2026

Status Verified

June 1, 2026

First QC Date

May 20, 2026

Last Update Submit

June 11, 2026

Interventions

RGX-202GENETIC

Sponsors & Collaborators

Study Sites (1)

Regenxbio

Rockville, Maryland, 20850, United States

Location

Study Design

Study Type
expanded access
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 20, 2026

First Posted

June 17, 2026

Last Updated

June 17, 2026

Record last verified: 2026-06

Locations

US(1)